Xbrane Biopharma AB (publ) (XBRANE.ST)
SEK 0.16
(-3.53%)
SEK 0.16
(-3.53%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -406.67 Million | -193.91 Million | -219.61 Million | -238.4 Million | -148.58 Million | 46.7 Million |
| Net Income | -322.02 Million | -172.51 Million | -188.37 Million | -226.02 Million | -166.03 Million | -13.11 Million |
| Depreciation & Amortization | 21.43 Million | 16.57 Million | 12.99 Million | 6.56 Million | 7.32 Million | 4.32 Million |
| Deferred income taxes | -1.83 Million | -25.42 Million | -9.06 Million | - | 12.35 Million | - |
| Stock-based compensation | 1.83 Million | 8.84 Million | 4.55 Million | 1.29 Million | 2.09 Million | 978 Thousand |
| Change in working capital | -119.15 Million | -30.73 Million | -38.41 Million | -18.62 Million | -7.27 Million | 54.86 Million |
| Other non-cash items | 11.23 Million | 9.32 Million | -1.3 Million | -1.61 Million | 2.94 Million | -348 Thousand |
| Investing Cash Flow | -16.76 Million | -60.12 Million | -77.35 Million | -3.85 Million | -1.18 Million | -1.59 Million |
| Investments in PPE | -16.76 Million | -60.12 Million | -77.35 Million | -3.85 Million | -1.18 Million | -1.59 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -9.97 Million | -48.5 Million | -49.67 Million | - | - | - |
| Financing Cash Flow | 298.69 Million | 148.86 Million | 349.36 Million | 322.72 Million | 216.04 Million | 47.73 Million |
| Debt repayment | -193.54 Million | -8.33 Million | -7.27 Million | -12 Thousand | -140 Thousand | -131 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 119.05 Million | 170.55 Million | 380.87 Million | 346.44 Million | 252.45 Million | 3.25 Million |
| Other Financing Activities | -1000.00 | -13.35 Million | -24.23 Million | -23.71 Million | -36.27 Million | 44.61 Million |
| Accounts receivables | -85.13 Million | 1.69 Million | -61.08 Million | -51.32 Million | -28.28 Million | -46.36 Million |
| Accounts payables | 22.57 Million | 17.82 Million | 22.67 Million | 32.69 Million | 42.96 Million | 103.5 Million |
| Inventory | -56.59 Million | -50.26 Million | -22.67 Million | -32.69 Million | - | -2.28 Million |
| Other working capital | 22.57 Million | 17.82 Million | 22.67 Million | 32.69 Million | -21.95 Million | 57.14 Million |
| Cash at beginning of period | 193.99 Million | 295.18 Million | 243.13 Million | 164.19 Million | 100.97 Million | 7.9 Million |
| Cash at end of period | 65.4 Million | 193.99 Million | 295.18 Million | 243.13 Million | 164.19 Million | 100.97 Million |
| Capital Expenditure | -16.76 Million | -60.12 Million | -77.35 Million | -3.85 Million | -1.18 Million | -1.59 Million |
| Effect of forex changes on cash | -4.48 Million | 4.04 Million | 1.39 Million | -1.52 Million | -3.03 Million | 230 Thousand |
| Net cash flow / Change in cash | -128.59 Million | -101.18 Million | 52.04 Million | 78.94 Million | 63.22 Million | 93.06 Million |
| Free Cash Flow | -423.44 Million | -254.04 Million | -296.96 Million | -242.26 Million | -149.77 Million | 45.1 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -45.11 Million | -70.5 Million | -97.1 Million | -322.02 Million | -92.64 Million | -81.23 Million |
| Depreciation & Amortization | 8.56 Million | 8.95 Million | 9.09 Million | 21.43 Million | 17.28 Million | 8.12 Million |
| Deferred income taxes | - | - | - | -1.83 Million | -1.83 Million | - |
| Stock-based compensation | - | - | - | 1.83 Million | 1.83 Million | - |
| Change in working capital | 14.84 Million | -28.06 Million | -30.01 Million | -119.15 Million | -5.52 Million | -44.43 Million |
| Other non-cash items | 15.37 Million | 35.74 Million | 53.02 Million | 11.23 Million | -2.07 Million | -7.86 Million |
| Investing Cash Flow | -23.89 Million | -10.54 Million | -501 Thousand | -16.76 Million | -176 Thousand | -187 Thousand |
| Investments in PPE | -23.89 Million | -10.54 Million | -501 Thousand | -16.76 Million | -176 Thousand | -187 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -23.89 Million | -10.54 Million | - | -9.97 Million | - | - |
| Financing Cash Flow | -3.19 Million | -85.96 Million | 316.02 Million | 298.69 Million | -14.1 Million | -23.27 Million |
| Debt repayment | - | -62.49 Million | -3.66 Million | -193.54 Million | -10.41 Million | -10.41 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | -19.93 Million | 319.69 Million | 119.05 Million | - | 18 Thousand |
| Other Financing Activities | -3.19 Million | 1000.00 | 319.69 Million | -1000.00 | -3.68 Million | -12.87 Million |
| Accounts receivables | -35.17 Million | -89.35 Million | 28.48 Million | -85.13 Million | 34.83 Million | 11.66 Million |
| Accounts payables | 48.61 Million | 113.82 Million | 21.92 Million | 22.57 Million | -67.17 Million | -19.04 Million |
| Inventory | 1.39 Million | -52.53 Million | -80.42 Million | -56.59 Million | 26.8 Million | -38.45 Million |
| Other working capital | 48.61 Million | 113.82 Million | - | 22.57 Million | 22.57 Million | 1.4 Million |
| Cash at beginning of period | 877 Thousand | 269.75 Million | 65.4 Million | 193.99 Million | 167.28 Million | 1.4 Million |
| Cash at end of period | 30.59 Million | 72.83 Million | 269.75 Million | 65.4 Million | 65.4 Million | 167.28 Million |
| Capital Expenditure | -23.89 Million | -10.54 Million | -501 Thousand | -16.76 Million | -176 Thousand | -187 Thousand |
| Effect of forex changes on cash | -311 Thousand | -1.06 Million | 1.93 Million | -4.48 Million | -6.57 Million | 372 Thousand |
| Net cash flow / Change in cash | 29.71 Million | -196.92 Million | 204.35 Million | -128.59 Million | -101.88 Million | 165.87 Million |
| Free Cash Flow | -38.8 Million | -110.07 Million | -113.7 Million | -423.44 Million | -81.3 Million | -125.59 Million |
MTGRF
AFP
3591
DCTH
2266
002736